Exponent(EXPO)
![icon](https://files.reportify.cn/fe-static/_next/static/media/search.b3fd6117.png?imageMogr2/quality/75/thumbnail/64x/format/webp)
Search documents
Exponent(EXPO) - 2023 Q3 - Quarterly Report
2023-11-02 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0218904 (State ...
Exponent(EXPO) - 2023 Q3 - Earnings Call Transcript
2023-10-27 00:53
Exponent Inc. (NASDAQ:EXPO) Q3 2023 Results Conference Call October 26, 2023 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Catherine Corrigan - President, CEO and Director Rich Schlenker - Executive VP, CFO and Corporate Secretary Conference Call Participants Tobey Sommer - Truist Josh Chan - UBS Andrew Nicholas - William Blair Operator Good day, and welcome to the Exponent Third Quarter Fiscal Year 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Oper ...
Exponent(EXPO) - 2023 Q2 - Quarterly Report
2023-08-06 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0218904 (State or o ...
Exponent(EXPO) - 2023 Q2 - Earnings Call Transcript
2023-07-28 00:31
Exponent, Inc. (NASDAQ:EXPO) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Dr. Catherine Corrigan - President and CEO Rich Schlenker - Executive Vice President and CFO Conference Call Participants Josh Chan - UBS Tobey Sommer - Truist Operator Good day. And welcome to the Exponent’s Second Quarter Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an ...
Exponent(EXPO) - 2023 Q1 - Quarterly Report
2023-05-04 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0218904 (State or ...
Exponent(EXPO) - 2023 Q1 - Earnings Call Transcript
2023-04-29 16:34
Exponent, Inc. (NASDAQ:EXPO) Q1 2023 Earnings Conference Call April 27, 2023 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Dr. Catherine Corrigan - President and CEO Rich Schlenker - Executive Vice President and CFO Conference Call Participants Andrew Nicholas - William Blair Tobey Sommer - Truist Securities Operator Good afternoon. And welcome to the Exponent First Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After tod ...
Exponent(EXPO) - 2022 Q4 - Annual Report
2023-02-23 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 30, 2022. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ________ to _________. Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) Delaware 77-0218904 (State or other jurisdiction ...
Exponent(EXPO) - 2022 Q4 - Earnings Call Transcript
2023-02-03 00:50
Exponent, Inc. (NASDAQ:EXPO) Q4 2022 Results Conference Call February 2, 2023 4:30 PM ET Company Participants Joni Konstantelos - IR Catherine Corrigan - President and Chief Executive Officer Rich Schlenker - Executive Vice President and Chief Financial Officer Conference Call Participants Jasper Bibb - Truist Andrew Nicholas - William Blair Operator Good day, and welcome to Exponent's Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. All participants will be in listen only mode [Operat ...
Exponent(EXPO) - 2022 Q3 - Quarterly Report
2022-11-03 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) | --- | --- | |----------- ...
Exponent(EXPO) - 2022 Q3 - Earnings Call Transcript
2022-10-27 21:33
Exponent, Inc. (NASDAQ:EXPO) Q3 2022 Earnings Conference Call October 27, 2022 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Catherine Ford Corrigan - President and Chief Executive Officer Richard Schlenker - Executive Vice President, Chief Financial Officer & Corporate Secretary Conference Call Participants Operator Good day and welcome to the Exponent, Incoporated Third Quarter of Fiscal Year 2022 Financial Results Conference Call. Today's conference is being recorded. And now at ...